United States securities and exchange commission logo





                             July 27, 2023

       James D. Swift, M.D.
       Chief Executive Officer
       Pediatrix Medical Group, Inc.
       1301 Concord Terrace
       Sunrise, FL 33323

                                                        Re: Pediatrix Medical
Group, Inc.
                                                            Definitive Proxy
Statement on Schedule 14A
                                                            Filed March 31,
2023
                                                            File No. 001-12111

       Dear James D. Swift:

               We have limited our review of your most recent definitive proxy
statement to those issues
       we have addressed in our comments. Please respond to these comments by
confirming that you
       will revise your future proxy disclosures in accordance with the topics
discussed below.

       Definitive Proxy Statement on Schedule 14A filed March 31, 2023

       Pay Versus Performance, page 58

   1.                                                   We note that you have
included Income (Loss) from Continuing Operations in column (h)
                                                        of your pay versus
performance table in lieu of net income (loss) as required by
                                                        Regulation S-K Item
402(v)(2)(v). Please include net income (loss), as reported in your
                                                        audited GAAP financial
statements, in column (h) for all years covered by the table. Refer
                                                        to Regulation S-K
Compliance and Disclosure Interpretations Questions 128D.08 and
                                                        128D.09. Please note
that you may voluntarily provide supplemental measures of
                                                        compensation or
financial performance, so long as any additional disclosure is clearly
                                                        identified as
supplemental, not misleading, and not presented with greater prominence
                                                        than the required
disclosure.
 James D. Swift, M.D.
FirstName  LastNameJames   D. Swift, M.D.
Pediatrix Medical Group, Inc.
Comapany
July       NamePediatrix Medical Group, Inc.
     27, 2023
July 27,
Page  2 2023 Page 2
FirstName LastName
       Please contact Eric Envall at 202-551-3234 or Charlie Guidry at
202-551-3621 with any
questions.



                                                         Sincerely,

                                                         Division of
Corporation Finance
                                                         Disclosure Review
Program